Navigation Links
Penn State researcher wins Entomological Society of America award
Date:10/20/2008

Consuelo M. De Moraes, associate professor of entomology, Penn State, is the first recipient of the Early Career Innovation Award from the Entomological Society of America (ESA).

The award honors young professionals working in entomology who have demonstrated innovation through contributions within any area of specialization research, teaching, extension, product development or public service. The award will be presented at the 2008 ESA Annual Meeting in Reno, Nev., on Nov. 16, 2008.

A native Brazilian, De Moraes earned her B.Sc. in ecology from the Universidade Federal de Minas Gerais. She received her doctorate in entomology from the University of Georgia. De Moraes' primary scientific interests are in understanding the critical roles of chemical communication in ecological interactions. She focuses on the role of plant volatiles in mediating interactions among plants and insects.

De Moraes' has also received a variety of awards, including a David and Lucile Packard Foundation Fellowship for Science and Engineering, the Beckman Young Investigator Award, and the DuPont Young Professor Award. She recently received a National Science Foundation CAREER award. De Moraes is active in teaching and outreach and is particularly committed to promoting the integration of minorities and women in science.


'/>"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. Penn State receives new NASA astrobiology grant
2. NC State takes lead in crime scene investigation training
3. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
4. NC State researchers get to root of parasite genome
5. Iowa State engineer works to clean and improve engine performance
6. Nitrate concentrations of ground water increasing in many areas of the United States
7. K-State professors USDA research shows mad cow disease also caused by genetic mutation
8. Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals
9. Stem cell research puts interstate rivalry on hold
10. NC State first university in nation to offer canine bone marrow transplants
11. Height linked to risk of prostate cancer development and progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...wire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a...etrics software, today reported financial results ... ,, Michael Tzannes, Aware,s Chairman and Chief...nced an agreement to sell our DSL and home network...ductor company being spun out of Infineon. This t...
(Date:11/4/2009)...-FirstCall/ -- BIO-key International, Inc. (OTC Bu...etric identification software is showcasing donor ...nference being held at the New Orleans Convention ...de hands-on product demonstrations of its state-of...Also, at 5 PM on Monday, October 26, Peter Lux, ma...
(Date:11/4/2009)...swire/ -- GenVault Corporation (Carlsbad, CA) toda...oined its Board of Directors. Dr. Brody, the Irwi... is an acclaimed physician-scientist and universit.... Brody served as president of The Johns Hopkins U... of Engineering and the Institute of Medicine, and...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases 28HTDS 29 57763 1Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases 28HTDS 29 57763 2ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 1ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 2ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 1Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 2Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 4
...new study explores the role of natural enemies, su... reproductive strategy in which hermaphroditic pla...ross-fertilization. The findings highlight the pos...ons. , Mating systems are a complex set of traits...ion structure, demography, and numerous environmen...
...a on soil quality and agriculture? How can soil he...xtent can biofuels help make America energy indepe...will be discussed at the International Annual Meet...op Science Society of America (CSSA), and Soil Sci...he Ernest N. Morial Convention Center in New Orlea...
...laug and Rob Horsch of the Gates Foundation will d...echnologies to feed the world to kick off the Inte...of Agronomy (ASA), Crop Science Society of America...) in New Orleans. They will speak on Sunday, Nov. ...on Riverside. , Horsch will present New Investmen...
Other Biology News:Predators and parasites may increase evolutionary stability 2Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings 2Norman Borlaug, Rob Horsch to keynote world hunger lecture 2
(Date:11/7/2009)...E, Mass., Nov. 7, Research project...red top marks this evening, as Tim Kunisky of Livi...(Jack) Chen of Audubon, PA received the highest ho... Competition in Math, Science & Technology, th.... ,, ( http://www.newscom.com/cgi-bin/prnh/200...
(Date:11/6/2009)...Mass., Nov. 6 Myriant Technologies...per and manufacturer of renewable bio-chemicals, ...nology provider Uhde GmbH, one of the world,s lead...unced an alliance for the engineering, procurement...ccinic Acid plants based on renewable feedstocks. ...
(Date:11/6/2009)... Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotec... "Company") today announced updated results from a...ents with sarcomas metastatic to the lung in a pos...sue Oncology Society Meeting held in Miami Beach, ...entation, entitled "A Phase II Study of Intravenou...
(Date:11/5/2009)...BURG, Md., Nov. 5 GenVec...ial results for the third quarter ended September ...on ($0.04 per share) for the three months ended Se...llion ($0.08 per share) in the comparable quarter ...009, GenVec,s net loss was $14.1 million ($0.15 pe...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Cell Biosciences, Inc., a,provider of nanoproteo...today,announced the launch of its first kits for t...y(TM) 3000 Protein Analysis System. The new kits a...he MEK and ERK families, which,play critical roles...evelopers,have targeted signaling via MEK and ERK ...
...ed Decision Support in Diabetes Drug Therapy , , ...shown statistically significant associations of ce...y mass index (BMI) and edema (fluid retention) in ...pioglitazone and rosiglitazone. The study, co-auth...r Affiliate at The Hospital of Central Connecticut...
...ic, a division of Simbionix USA,Corporation (Simbi...ducts and,technology for training medical salespeo.... Williams joined the company as Sales Executive f...out of a new office located in,Grayslake, Illinois...rning technologies and medical,procedures. His pri...
Other Biology Technology:Cell Biosciences Introduces Kits for Oncoprotein Analysis 2Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study 2Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office 2
Calf Serum, Iron-Supplemented from Sigma-Aldrich
...NA Polymerase is a thermostable DNA polymerase der...ty at temperatures above 70°C, it was the fir...e predominant enzyme for that purpose. The enzyme ...ease activity, but lacks 3'--5' proofreading exonu...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
...radient system uses three Adept CE 4100 high pres... in one microlitre increaments. The Adept CE 4200...System control and data processing is provided by ... unit, CE 4900., Column heater/chillers can be su...
Biology Products: